Validation of LC-MS electrospray ionisation method for quantitation of haloperidol in human plasma and its application to bioequivalence study

Analytica Chimica Acta

Volumn 551, Issue 1-2, 2005, Pages 159-167

  Singh, Sonu Sundd ^a   Sharma, Kuldeep ^a  

^a ZYDUS RESEARCH CENTRE   (India)

Author keywords

Bioequivalence; Haloperidol; Method validation

Indexed keywords

AMMONIUM COMPOUNDS; BODY FLUIDS; CONCENTRATION (PROCESS); EXTRACTION; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMAS;

BIOEQUIVALENCE; HALOPERIDOL; HUMAN PLASMAS; METHOD VALIDATION;

DRUG PRODUCTS;

ACETONITRILE; AMMONIUM ACETATE; DULOXETINE; HALOPERIDOL; NEUROLEPTIC AGENT;

ACCURACY; ARTICLE; BIOEQUIVALENCE; CONCENTRATION (PARAMETERS); CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PH MEASUREMENT; PLASMA; PRIORITY JOURNAL; PURIFICATION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; VALIDATION PROCESS;

EID: 25844477027     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2005.07.046     Document Type: Article

References (20)

1. S. Kudo, and T. Ishizaki Clin. Pharmacokinetic 37 5 1999 435
2. K.K. Midha, B.S. Chakarborty, D.A. Ganes, E.M. Hawes, J.W. Hubbard, D.L. Kecgan, E.D. Korchinski, and G. Mckay J. Clin. Psychopharmacol. 9 2 1984 98
3. J. de Leon, F.J. Diaz, P. Wedlund, R.C. Josiassen, T.B. Cooper, and G.M. Simpson J. Clin. Psychopharmacol. 24 6 2004 656
4. N. Yasui Furukori, Y. Inoue, M. Chiba, and T. Tateishi J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 805 1 2004 175
5. K. Titier, S. Bouchet, F. Pehourcq, N. Moore, and M. Molimard J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 788 1 2003 179
6. A.K. Dhar, and H. Kutt Clin. Chem. 30 1984 1228
7. L. Pan, M.T. Rosseel, and F.M. Belpaire Ther. Drug. Monit. 20 2 1998 224
8. M.K. Samanta, R. Dube, and B. Suresh Indian J. Pharm. Sci. 61 4 1999 219
9. K.K. Midha, B.S. Chakarborty, R. Schwede, E.M. Hawes, J.W. Hubbard, and G.J. Mc Kay Pharm. Sci. 78 6 1989 443
10. N. Yasui-Furukori, Y. Inoue, M. Chiba, and T. Tateishi J. Chromatogr. B 805 2004 175
11. M. Aravagiri, S.R. Marder, T.V. Putten, and B.D. Marshall J. Chromatogr. B: Biomed. Sci. Appl. 656 1994 373
12. T. Fujii, K. Hatanakaa, G. Satob, Y. Yasuic, H. Arimotoc, and Y. Mitsutsukad J. Chromatogr. B: Biomed Sci. Appl. 687 1996 395
13. S.-M. Wu, W.-K. Ko, H.-L. Wu, and S.-H. Chen J. Chromatogr. A 846 1999 239
14. A.J. Tomlinson, L.M. Benson, J.P. Landers, and G.F. Scalan J. Chromatogr. A 652 1993 417
15. T. Arinobu, H. Hattori, H. Seno, A. Ishii, and O. Suzuki J. Am. Soc. Mass Spectrom. 13 3 2002 204
16. T. Arinobu, H. Hattori, H. Seno, A. Ishii, and O. Suzuki J. Am. Soc. Mass Spectrom. 13 3 2002 204
17. H. Hoja, P. Marquet, B. Verneuil, H. Lotfi, J.L. Dupuy, B. Penicaut, and G. Lachatre J. Chromatogr. B Biomed. Sci. Appl. 688 2 1997 275
18. Guidance for industry, Bioanalytical method validation. US Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for veterinary Medicine (CVM) May 2001 BP. Website: http://www.fda.gov/cder/guidance/index.htm.
19. FDA Guidance for Industry, Biaoavaliability Studies for Orally Administered Drug - Products-General Considerations, US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER) 2000. Website: http://www.fda.gov/cder/guidance/index.htm.
20. FDA Guidance for Industry, Statistical Approaches to Establishing Bioequivalence, US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER) 2001. Website: http://www.fda.gov/cder/guidance/index.htm